NGM Biopharmaceuticals
NGM
#8634
Rank
A$0.20 B
Marketcap
$2.45
Share price
0.00%
Change (1 day)
-50.83%
Change (1 year)

NGM Biopharmaceuticals (NGM) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : A$32.2 Million

According to NGM Biopharmaceuticals's latest financial reports the company's total liabilities are A$32.2 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NGM Biopharmaceuticals - Total liabilities on balance sheet (from 2017 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$29.69 M-57.76%
2022-12-31A$70.3 M-23.63%
2021-12-31A$92.05 M44.46%
2020-12-31A$63.72 M-10.2%
2019-12-31A$70.96 M-85.89%
2018-12-31A$0.50 B6.14%
2017-12-31A$0.47 B-12.88%
2016-12-31A$0.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$19.35 M-39.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.35 B 4,114.96%๐Ÿ‡บ๐Ÿ‡ธ USA